290 related articles for article (PubMed ID: 31234826)
1. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
[TBL] [Abstract][Full Text] [Related]
2. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
4. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
5. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
[TBL] [Abstract][Full Text] [Related]
6. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
7. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
[TBL] [Abstract][Full Text] [Related]
8. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.
Millares L; Ferrari R; Gallego M; Garcia-Nuñez M; Pérez-Brocal V; Espasa M; Pomares X; Monton C; Moya A; Monsó E
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1101-11. PubMed ID: 24449346
[TBL] [Abstract][Full Text] [Related]
9. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
F1000Res; 2023; 12():528. PubMed ID: 37928173
[No Abstract] [Full Text] [Related]
10. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
Wang J; Chai J; Sun L; Zhao J; Chang C
BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
[TBL] [Abstract][Full Text] [Related]
11. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
[TBL] [Abstract][Full Text] [Related]
12. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
13. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
[TBL] [Abstract][Full Text] [Related]
14. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
16. Short term dynamics of the sputum microbiome among COPD patients.
Sinha R; Weissenburger-Moser LA; Clarke JL; Smith LM; Heires AJ; Romberger DJ; LeVan TD
PLoS One; 2018; 13(3):e0191499. PubMed ID: 29518088
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
[TBL] [Abstract][Full Text] [Related]
18. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.
Zanini A; Cherubino F; Zampogna E; Croce S; Pignatti P; Spanevello A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1155-61. PubMed ID: 26124655
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
20. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
Xiao W; Du LY; Mao B; Miao TW; Fu JJ
BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]